Kamini Jakhar
Faridabad, HR 120001, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Serological Assays to Measure Rabies Antibody Response in Equine Serum Samples.
Journal: Viruses
Published: November 06, 2025
SARS-CoV-2 spike antibodies cross-react with dengue virus and enhance infection in vitro and in vivo.
Journal: Frontiers in immunology
Published: October 14, 2025
CoviWall, a whole-virion-inactivated B.1.617.2 vaccine candidate, induces potent humoral and Th1 cell response in mice and protects against B.1.617.2 strain challenge in Syrian hamsters.
Journal: Frontiers in immunology
Published: June 12, 2024
Targeting host inducible-heat shock protein 70 with PES-Cl is a promising antiviral strategy against SARS-CoV-2 infection and pathogenesis.
Journal: International journal of biological macromolecules
Published: January 25, 2024
Trends of humoral immune responses to heterologous antigenic exposure due to vaccination & omicron SARS-CoV-2 infection: Implications for boosting.
Journal: The Indian journal of medical research
Published: June 16, 2023
Targeting DPP4-RBD interactions by sitagliptin and linagliptin delivers a potential host-directed therapy against pan-SARS-CoV-2 infections.
Journal: International journal of biological macromolecules
Published: February 15, 2023
Characterization of a broadly cross reactive tetravalent human monoclonal antibody, recognizing conformational epitopes in receptor binding domain of SARS-CoV-2.
Journal: 3 Biotech
Published: April 27, 2022
A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant.
Journal: PLoS pathogens
Published: January 12, 2022
High failure rate of ChAdOx1-nCoV19 immunization against asymptomatic infection in healthcare workers during a Delta variant surge.
Journal: Nature communications
Published: November 24, 2021
The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41.
Journal: International immunopharmacology
Published: July 26, 2021
Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus.
Journal: International immunopharmacology
Published: May 12, 2021
Last Updated: 09/26/2026